A11 Follow up results

Table A11.1a: Risk of a significant cervical abnormality, first follow-up episodes, by age, 2024

Age group

Low risk

Intermediate risk

Higher risk

Screening episodes

25–29

3,138

4,917

269

8,439

30–34

1,790

2,280

186

4,331

35–39

1,376

1,617

137

3,182

40–44

1,091

1,374

101

2,613

45–49

925

1,069

102

2,133

50–54

817

987

107

1,962

55–59

636

884

82

1,667

60–64

551

866

49

1,543

65–69

450

647

51

1,218

70–74

73

118

11

211

25–74

10,847

14,759

1,095

27,299

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.1b: Risk of a significant cervical abnormality, first follow-up episodes, by age, 2024

Age group

Low risk

Intermediate risk

Higher risk

25–29

37.2

58.3

3.2

30–34

41.3

52.6

4.3

35–39

43.2

50.8

4.3

40–44

41.8

52.6

3.9

45–49

43.4

50.1

4.8

50–54

41.6

50.3

5.5

55–59

38.2

53.0

4.9

60–64

35.7

56.1

3.2

65–69

36.9

53.1

4.2

70–74

34.6

55.9

5.2

25–74

39.7

54.2

4.0

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.2a: Risk of a significant cervical abnormality, first follow-up episodes, by state and territory, 2024

State and territory

Low risk

Intermediate risk

Higher risk

Screening episodes

NSW

2,940

4,521

367

7,956

Vic

3,475

3,988

293

7,997

Qld

2,211

3,044

199

5,578

WA

1,146

1,597

109

2,898

SA

558

938

82

1,610

Tas

220

253

23

512

ACT

188

282

16

493

NT

107

136

6

253

Australia

10,847

14,759

1,095

27,299

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.2b: Risk of a significant cervical abnormality, first follow-up episodes, by state and territory, 2024

State and territory

Low risk

Intermediate risk

Higher risk

NSW

37.0

56.8

4.6

Vic

43.5

49.9

3.7

Qld

39.6

54.6

3.6

WA

39.5

55.1

3.8

SA

34.7

58.3

5.1

Tas

43.0

49.4

4.5

ACT

38.1

57.2

3.2

NT

42.3

53.8

2.4

Australia

39.7

54.1

4.0

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.3a: Risk of a significant cervical abnormality, first follow-up episodes, by year, 2018 to 2024

Year

Low risk

Intermediate risk

Higher risk

Screening episodes

2018

741

. .

1,551

2,295

2019

19,357

. .

33,753

53,166

2020

21,370

. .

34,965

56,400

2021

11,283

16,603

1,555

29,653

2022

8,749

12,696

1,062

22,751

2023

7,727

11,188

823

20,075

2024

10,847

14,759

1,095

27,299

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.3b: Risk of a significant cervical abnormality, first follow-up episodes, by year, 2018 to 2024

Year

Low risk

Intermediate risk

Higher risk

2018

32.3

. .

67.6

2019

36.4

. .

63.5

2020

37.9

. .

62.0

2021

38.1

56.0

5.2

2022

38.5

55.8

4.7

2023

38.5

55.7

4.1

2024

39.7

54.1

4.0

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.4a: Risk of a significant cervical abnormality, second follow-up episodes, by age, 2024

Age group

Low risk

Higher risk

Screening episodes

25–29

1,747

3,800

5,559

30–34

1,044

2,336

3,389

35–39

684

1,368

2,061

40–44

417

938

1,356

45–49

314

710

1,028

50–54

166

440

606

55–59

134

400

536

60–64

117

496

615

65–69

76

425

502

70–74

18

82

100

25–74

4,717

10,995

15,752

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.4b: Risk of a significant cervical abnormality, second follow-up episodes, by age, 2024

Age group

Low risk

Higher risk

25–29

31.4

68.4

30–34

30.8

68.9

35–39

33.2

66.4

40–44

30.8

69.2

45–49

30.5

69.1

50–54

27.4

72.6

55–59

25.0

74.6

60–64

19.0

80.7

65–69

15.1

84.7

70–74

18.0

82.0

25–74

29.9

69.8

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.5a: Risk of a significant cervical abnormality, second follow-up episodes, by state and territory, 2024

State and territory

Low risk

Higher risk

Screening episodes

NSW

1,277

3,515

4,806

Vic

1,481

2,918

4,411

Qld

878

1,892

2,774

WA

611

1,446

2,063

SA

236

671

910

Tas

94

203

297

ACT

89

239

329

NT

51

111

162

Australia

4,717

10,995

15,752

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.5b: Risk of a significant cervical abnormality, second follow-up episodes, by state and territory, 2024

State and territory

Low risk

Higher risk

NSW

26.6

73.1

Vic

33.6

66.2

Qld

31.7

68.2

WA

29.6

70.1

SA

25.9

73.7

Tas

31.6

68.4

ACT

27.1

72.6

NT

31.5

68.5

Australia

29.9

69.8

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.6a: Risk of a significant cervical abnormality, second follow-up episodes, by year, 2021 to 2024

Year

Low risk

Higher risk

Screening episodes

2021

1,329

3,369

4,700

2022

5,489

12,539

18,055

2023

5,230

12,033

17,292

2024

4,717

10,995

15,752

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Table A11.6b: Risk of a significant cervical abnormality, second follow-up episodes, by year, 2021 to 2024

Year

Low risk

Higher risk

2021

28.3

71.7

2022

30.4

69.4

2023

30.2

69.6

2024

29.9

69.8

Source: AIHW analysis of NCSR data (NCSR RDE 11/07/2025).

Previous page
Next page